Compare

Harvard Bioscience Inc vs 908 Devices Inc. vs Quanterix Corp vs Pacific Biosciences of California, Inc.

Latest annual figures from SEC filings. Each company is shown for its own most recent fiscal year, so period ends can differ. Select a figure to see its full history.

Latest fiscal year	Harvard Bioscience Inc HBIO	908 Devices Inc. MASS	Quanterix Corp QTRX	Pacific Biosciences of California, Inc. PACB
Year ended	2025-12-31	2025-12-31	2025-12-31	2025-12-31
Revenue	$86.55M	$56.20M	$138.90M	$160.00M
Revenue growth (YoY)	-8.1%	+17.7%	+1.1%	+3.9%
Gross margin	57.7%	50.6%	46.8%	28.6%
Operating margin	-56.1%	-70.1%	-90.4%	-346.2%
Net margin	-65.5%	34.7%	-77.1%	-341.5%
Net income	-$56.70M	$19.49M	-$107.15M	-$546.38M
EPS (Diluted)	-$1.28	$0.54	-$2.51	-$1.82
Operating cash flow	$6.73M	-$23.69M	-$77.24M	-$111.21M
Free cash flow	$5.47M	-$24.64M	-$79.85M	-$113.92M
Cash & equivalents	$8.61M	$70.52M	$29.84M	$63.71M
Total assets	$80.07M	$190.07M	$418.77M	$784.08M
Total liabilities	$66.34M	$46.37M	$123.04M	$778.73M
Shareholders' equity	$13.73M	$143.70M	$295.73M	$5.35M
Return on year-end equity	-412.8%	13.6%	-36.2%	n/m
Shares outstanding	44.72M	36.32M	46.74M	301.96M

n/a means the company did not report that line under the concept TickerFacts maps, not that it is zero.

Revenue, most recent five fiscal years

Fiscal year	Harvard Bioscience Inc	908 Devices Inc.	Quanterix Corp	Pacific Biosciences of California, Inc.
Latest	$86.55M Ended 2025-12-31	$56.20M Ended 2025-12-31	$138.90M Ended 2025-12-31	$160.00M Ended 2025-12-31
1 year earlier	$94.14M Ended 2024-12-31	$47.75M Ended 2024-12-31	$137.42M Ended 2024-12-31	$154.01M Ended 2024-12-31
2 years earlier	$112.25M Ended 2023-12-31	$50.23M Ended 2023-12-31	$122.37M Ended 2023-12-31	$200.52M Ended 2023-12-31
3 years earlier	$113.33M Ended 2022-12-31	$46.85M Ended 2022-12-31	$105.52M Ended 2022-12-31	$128.30M Ended 2022-12-31
4 years earlier	$118.90M Ended 2021-12-31	$42.21M Ended 2021-12-31	$110.56M Ended 2021-12-31	$130.51M Ended 2021-12-31